Bright sunshine beamed down on the distinguished ten guests who gathered to receive an honorary degree from the University of Cambridge on 22 June. The conferment of honorary degrees is one of the highest accolades the University can bestow upon people who have made outstanding achievements in their respective fields.
Launched today at the CAm Board meeting, “A Century of Friendship: A History of Cambridge Philanthropy in America” is a fascinating and lively 80-page chronicle of CAm, the organizations that preceded it, its history, its people, and the way that it has helped shape American philanthropy for Collegiate Cambridge.
This year’s cohort comprises 79 new scholars. The scholars, who come from 30 countries, will begin their studies in October. They are studying subjects ranging from food security and bat reservoirs for viral diseases to how gut hormones control food intake and blood glucose levels. The class comprises 41 women and 38 men.
Prime Minister Boris Johnson announced that DIOSynVax, a biotech spinout of the University of Cambridge, will receive $42 million (about £32 million) to develop a vaccine candidate that could provide protection against both existing and future variants of SARS-CoV-2 – the virus that causes COVID-19 – as well as other major coronaviruses, including those that cause SARS and MERS.
The University of Cambridge has become the first Higher Education institution outside of the USA to partner with the Posse Foundation, offering graduate studentships to young people from under-represented backgrounds.